Precipio Inc. (PRPO)
NASDAQ: PRPO
· Real-Time Price · USD
6.21
-0.10 (-1.58%)
At close: May 06, 2025, 3:47 PM
6.21
0.00%
After-hours: May 06, 2025, 04:00 PM EDT
-1.58% (1D)
| Bid | 6 |
| Market Cap | 9.41M |
| Revenue (ttm) | 17.92M |
| Net Income (ttm) | -4.29M |
| EPS (ttm) | -2.93 |
| PE Ratio (ttm) | -2.12 |
| Forward PE | 0.25 |
| Analyst | n/a |
| Ask | 6.83 |
| Volume | 22,560 |
| Avg. Volume (20D) | 13,001 |
| Open | 6.25 |
| Previous Close | 6.31 |
| Day's Range | 6.02 - 6.92 |
| 52-Week Range | 3.90 - 10.74 |
| Beta | 1.12 |
About PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the se...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 30, 2017
Employees 54
Stock Exchange NASDAQ
Ticker Symbol PRPO
Website https://www.precipiodx.com
9 months ago
+23.87%
Precipio shares are trading higher after the compa...
Unlock content with
Pro Subscription
